Global (R)-Nipecotic acid ethyl ester market was valued at USD 18.6 million in 2025 and is projected to reach USD 34.2 million by 2034, exhibiting a remarkable CAGR of 7.1% during the forecast period.
(R)-Nipecotic acid ethyl ester is a specialized chiral pharmaceutical intermediate derived from nipecotic acid, valued for its role as a selective GABA uptake inhibitor. It has transitioned...